Methods of making and using chemically self assembled-nanorings
Provided herein are compounds, conjugates and methods for making lipid-chemically self-assembled nanorings (Lipid-CSANs) and using them to treat diseases and modify cell surfaces.
1. A compound of formula I:
wherein:
A is a divalent, branched or unbranched, saturated or unsaturated, hydrocarbon chain, having from 2 to 25 carbon atoms, wherein one or more of the carbon atoms is optionally replaced by (—O—), and wherein the chain is optionally substituted on carbon with one or more substituents selected from (C 1 -C 6 )alkoxy, (C 3 -C 6 )cycloalkyl, (C 1 -C 6 )alkanoyl, (C 1 -C 6 )alkanoyloxy, (C 1 -C 6 )alkoxycarbonyl, (C 1 -C 6 )alkylthio, azido, cyano, nitro, halo, hydroxy, oxo (═O), carboxy, aryl, aryloxy, heteroaryl, and heteroaryloxy;
B is a divalent, branched or unbranched, saturated or unsaturated, hydrocarbon chain, having from 2 to 25 carbon atoms, wherein one or more of the carbon atoms is optionally replaced by (—O—), and wherein the chain is optionally substituted on carbon with one or more substituents selected from (C 1 -C 6 )alkoxy, (C 3 -C 6 )cycloalkyl, (C 1 -C 6 )alkanoyl, (C 1 -C 6 )alkanoyloxy, (C 1 -C 6 )alkoxycarbonyl, (C 1 -C 6 )alkylthio, azido, cyano, nitro, halo, hydroxy, oxo (═O), carboxy, aryl, aryloxy, heteroaryl, and heteroaryloxy;
X is N or
Y is a divalent, branched or unbranched, saturated or unsaturated, hydrocarbon chain, having from 20 to 250 carbon atoms, wherein one or more of the chain carbon atoms is optionally replaced by O, S, NR a , (C═O) or a 5 or 6-membered heterocycle, wherein each R a is independently H or (C 1 -C 6 )alkyl, and wherein the chain is optionally substituted on carbon with one or more substituents selected from (C 1 -C 6 )alkoxy, (C 3 -C 6 )cycloalkyl, (C 1 -C 6 )alkanoyl, (C 1 -C 6 )alkanoyloxy, (C 1 -C 6 )alkoxycarbonyl, (C 1 -C 6 )alkylthio, azido, cyano, nitro, halo, hydroxy, oxo (═O), carboxy, aryl, aryloxy, heteroaryl and heteroaryloxy;
R 1 is a branched or unbranched, saturated or unsaturated, hydrocarbon chain, having from 3 to 30 carbon atoms; and
R 2 is a branched or unbranched, saturated or unsaturated, hydrocarbon chain, having from 3 to 30 carbon atoms;
or a salt thereof.
2. The compound of claim 1 which is a compound of formula Ia:
wherein:
A is a divalent, branched or unbranched, saturated or unsaturated, hydrocarbon chain, having from 2 to 25 carbon atoms, wherein one or more of the carbon atoms is optionally replaced by (—O—), and wherein the chain is optionally substituted on carbon with one or more substituents selected from (C 1 -C 6 )alkoxy, (C 3 -C 6 )cycloalkyl, (C 1 -C 6 )alkanoyl, (C 1 -C 6 )alkanoyloxy, (C 1 -C 6 )alkoxycarbonyl, (C 1 -C 6 )alkylthio, azido, cyano, nitro, halo, hydroxy, oxo (═O), carboxy, aryl, aryloxy, heteroaryl, and heteroaryloxy;
B is a divalent, branched or unbranched, saturated or unsaturated, hydrocarbon chain, having from 2 to 25 carbon atoms, wherein one or more of the carbon atoms is optionally replaced by (—O—), and wherein the chain is optionally substituted on carbon with one or more substituents selected from (C 1 -C 6 )alkoxy, (C 3 -C 6 )cycloalkyl, (C 1 -C 6 )alkanoyl, (C 1 -C 6 )alkanoyloxy, (C 1 -C 6 )alkoxycarbonyl, (C 1 -C 6 )alkylthio, azido, cyano, nitro, halo, hydroxy, oxo (═O), carboxy, aryl, aryloxy, heteroaryl, and heteroaryloxy;
X is N or
Y is a divalent, branched or unbranched, saturated or unsaturated, hydrocarbon chain, having from 20 to 250 carbon atoms, wherein one or more of the chain carbon atoms is optionally replaced by O, S, NR a , (C═O) or a 5 or 6-membered heterocycle, wherein each R a is independently H or (C 1 -C 6 )alkyl, and wherein the chain is optionally substituted on carbon with one or more substituents selected from (C 1 -C 6 )alkoxy, (C 3 -C 6 )cycloalkyl, (C 1 -C 6 )alkanoyl, (C 1 -C 6 )alkanoyloxy, (C 1 -C 6 )alkoxycarbonyl, (C 1 -C 6 )alkylthio, azido, cyano, nitro, halo, hydroxy, oxo (═O), carboxy, aryl, aryloxy, heteroaryl and heteroaryloxy;
R 1 is a branched or unbranched, saturated or unsaturated, hydrocarbon chain, having from 3 to 30 carbon atoms; and
R 2 is a branched or unbranched, saturated or unsaturated, hydrocarbon chain, having from 3 to 30 carbon atoms;
or a salt thereof.
3. The compound of claim 1 , wherein A is a divalent, branched or unbranched, saturated or unsaturated, hydrocarbon chain, having from 3 to 10 carbon atoms, wherein one or more carbon atoms is optionally replaced with an oxygen (—O—) atom in the chain, wherein the chain is optionally substituted on carbon with one or more substituents selected from (C 1 -C 6 )alkoxy, (C 3 -C 6 )cycloalkyl, (C 1 -C 6 )alkanoyl, (C 1 -C 6 )alkanoyloxy, (C 1 -C 6 )alkoxycarbonyl, (C 1 -C 6 )alkylthio, azido, cyano, nitro, halo, hydroxy, oxo (═O), carboxy, aryl, aryloxy, heteroaryl, and heteroaryloxy.
4. The compound of claim 1 , wherein A is a divalent, branched or unbranched, saturated or unsaturated, hydrocarbon chain, having from 3 to 10 carbon atoms.
5. The compound of claim 1 , wherein B is a divalent, branched or unbranched, saturated or unsaturated, hydrocarbon chain, having from 3 to 10 carbon atoms, wherein one or more carbon atoms is optionally replaced with an oxygen (—O—) atom in the chain, wherein the chain is optionally substituted on carbon with one or more substituents selected from (C 1 -C 6 )alkoxy, (C 3 -C 6 )cycloalkyl, (C 1 -C 6 )alkanoyl, (C 1 -C 6 )alkanoyloxy, (C 1 -C 6 )alkoxycarbonyl, (C 1 -C 6 )alkylthio, azido, cyano, nitro, halo, hydroxy, oxo(═O), carboxy, aryl, aryloxy, heteroaryl, and heteroaryloxy.
6. The compound of claim 1 , wherein B is a divalent, branched or unbranched, saturated or unsaturated, hydrocarbon chain, having from 3 to 10 carbon atoms.
7. The compound of claim 1 , wherein X is N.
8. The compound of claim 1 , wherein R 1 is a branched or unbranched, saturated or unsaturated, hydrocarbon chain, having from 10 to 25 carbon atoms.
9. The compound of claim 1 , wherein R 2 is a branched or unbranched, saturated or unsaturated, hydrocarbon chain, having from 10 to 25 carbon atoms.
10. The compound of claim 1 , wherein Y has a molecular weight of from about 200 daltons to about 10,000 daltons.
11. The compound of claim 1 , wherein Y is divalent, branched or unbranched, saturated or unsaturated, hydrocarbon chain, having from 50 to 250 carbon atoms, wherein one or more of the chain carbon atoms is optionally replaced by O, S, NR a , (C═O) or a 5 or 6-membered heterocycle and wherein each R a is independently H or (C 1 -C 6 )alkyl.
12. The compound of claim 1 , wherein Y is divalent, branched or unbranched, saturated or unsaturated, hydrocarbon chain, having from 100 to 250 carbon atoms, wherein one or more of the chain carbon atoms is optionally replaced by O, S, NR a , (C═O) or a 5 or 6-membered heterocycle and wherein each R a is independently H or (C 1 -C 6 )alkyl.
13. The compound of claim 1 , wherein Y is divalent, branched or unbranched, saturated or unsaturated, hydrocarbon chain, having from 100 to 200 carbon atoms, wherein one or more of the chain carbon atoms is optionally replaced by O, S, NR a , (C═O) or a 5 or 6-membered heterocycle and wherein each R a is independently H or (C 1 -C 6 )alkyl.
14. The compound of claim 12 , wherein one or more of the chain carbon atoms is optionally replaced by O, S, NR a or (C═O) wherein each R a is independently H or (C 1 -C 6 )alkyl and wherein 1, 2 or 3 of the chain carbon atoms is optionally replaced by a 5 or 6-membered heterocycle.
15. The compound of claim 1 which is:
or a salt thereof.
16. A conjugate comprising a compound of formula I or a salt thereof as described in claim 1 , wherein the conjugate further comprises a first dihydrofolate reductase (DHFR) molecule linked to second DHFR molecule via a linker.
17. A composition comprising a compound of formula I or a pharmaceutically acceptable salt thereof or a conjugate of formula I or a pharmaceutically acceptable salt thereof as described in claim 1 and a pharmaceutically acceptable carrier.
18. A method for treating cancer in a patient in need of such treatment, comprising administering to the patient a therapeutically effective amount of a compound of formula I or a pharmaceutically acceptable salt thereof as described in claim 1 .
19. A method to modify the surface of a cell comprising contacting the cell in vitro or in vivo with a compound of formula I or a pharmaceutically acceptable salt thereof as described in claim 1 .